News in the Life Sciences Industry

ZUG, Switzerland, Nov. 18, 2020 /PRNewswire/ -- Pharvaris, a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor... Read more ››

NEW YORK and BASEL, Switzerland, Nov. 16, 2020 /PRNewswire/ -- Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene therapies for the treatment of rare diseases, today announced that the European Medicines Agency (EMA) has granted orphan... Read more ››

Project Lucy Submits Pre-IND Briefing Package to the FDA; Agrees Q1 Interim Analysis of Swiss Phase 2a Trial of LSD Assisted Therapy for Anxiety Disorders

SHANGHAI, Nov. 16, 2020 /PRNewswire/ -- Cytiva, a global life sciences leader, is supporting Clover Biopharmaceuticals, a global clinical-stage biotechnology company, to help accelerate the development and manufacturing of a protein-based S-Trimer subunit vaccine candidate. With promising preliminary... Read more ››

ZUG, Switzerland, Nov. 13, 2020 /PRNewswire/ -- Pharvaris, a clinical-stage company focused on the discovery and development of novel oral bradykinin-B2-receptor... Read more ››

VEVEY, Switzerland, Nov. 13, 2020 /PRNewswire/ -- On November 13(th), 2020, AlpVision is launching the "AlpVision COVID-19 Initiative" helping pharmaceutical companies to protect COVID-19 relevant medicines against counterfeiting.

CHICAGO, BASEL, Switzerland and NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Roivant Sciences today named EVERSANA(TM), the pioneer of next-generation... Read more ››

ZUG, Switzerland, Nov. 12, 2020 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform to deliver innovative, safe, and broadly accessible treatments to patients with potentially life-threatening conditions,... Read more ››